주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Thursday, Aprill 18, 2024, 17:11
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Bioepis Announces Results of Humira Biosimilar Interchangeability Study in US
이미지기사
Healthcare & Bio
Jasmine Choi
03.11 12:06
Celltrion Achieves Successive Orders for Autoimmune Disease Similars in Europe
이미지기사
Healthcare & Bio
Jasmine Choi
01.12 18:04
Integrated Celltrion to Launch: Global Big Pharma Firm with 12 Trillion Won Revenue
이미지기사
Healthcare & Bio
Choi Mun-hee
2023.12.28 09:09
Celltrion Announces Phase 3 Clinical Trial Results for CT-P17, Humira
이미지기사
Healthcare & Bio
Jasmine Choi
2023.12.27 15:14
[Celltrion Healthcare] Upward revision to 2024F earnings for merged Celltrion group
이미지기사
Company & Stock Tracking
Pyeongkuk Park
2023.11.09 13:58
Celltrion Secures Additional FDA Approval for Yuflyma Dosages in US
이미지기사
Healthcare & Bio
Jasmine Choi
2023.10.05 02:56
Biopharmaceuticals Added to National Strategic Technology List, Eligible for Up to 35% Tax Deduction
이미지기사
Industries
Kim Eun-jin
2023.07.28 11:08
US Truxima price falls more than expected
이미지기사
Finance
Pyeongkuk Park
2023.07.17 18:39
Samsung Bioepis, Humira Biosimilar Listed by US PBM Prime
이미지기사
Industries
Jasmine Choi
2023.07.14 10:42
Samsung Bioepis, Celltrion to Target US$20 Billion US Humira Similar Market
이미지기사
Industries
Jung Suk-yee
2023.07.03 09:38
Celltrion Starts Development of Oral Form of Humira Biosimilar CT-P17
이미지기사
Science/Tech
Jasmine Choi
2023.06.05 19:58
Taking another good look
이미지기사
Finance
Jaewon Jeong
2023.05.23 10:47
Entering profit margin normalization phase on solid US prescriptions and one-off cost relief
이미지기사
Finance
Pyeongkuk Park
2023.04.10 17:42
South Korean New Drugs Enjoying Sales Growth in the U.S.
이미지기사
Lifestyle
Choi Moon-hee
2023.02.27 11:50
Samsung Biologics: Ushering in Era of Over KRW3tn in Annual Revenue
이미지기사
Finance
Kim Tae-hee
2023.01.31 08:43
Samsung Biologics: All Eyes on Plant 5 and Samsung Bioepis
이미지기사
Finance
Lee Dong-gun
2023.01.04 09:32
Samsung Biologics: Plant #4 to Contribute to Growth after Preparation Period in 2023
이미지기사
Finance
Park Pyeong-kuk
2023.01.04 09:23
Humira Biosimilar Market About to Open in the U.S.
이미지기사
Lifestyle
Jung Suk-yee
2022.12.13 12:28
2023 Outlook: Bio: It’s Time for Biotech Firms to Outshine S&P500 Healthcare Players
Finance
Park Pyeong-kuk
2022.11.23 11:04
Samsung Biologics: 3Q22 Earnings Beat Despite Raised Market Consensus
이미지기사
Finance
Kim Tae-hee
2022.10.28 09:21
처음
1
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기